東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Biologic therapy for psoriasis = cut...

Brownstone, Nicholas.

Linked to FindBook

Google Book

Amazon

博客來

Biologic therapy for psoriasis = cutting edge treatment principles /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Biologic therapy for psoriasis/ edited by Nicholas Brownstone, Tina Bhutani, Wilson Liao.
Reminder of title:	cutting edge treatment principles /
other author:	Brownstone, Nicholas.
Published:	Cham :Springer International Publishing : : 2022.,
Description:	xvii, 146 p. :ill., digital ;24 cm.
[NT 15003449]:	Introduction to Biologic Therapy for Psoriasis -- Laboratory Monitoring: TB, Hepatitis and HIV -- TNF-Alpha Class of Biologic Agents in Psoriatic Disease -- IL-17 class of Biologic Agents in Psoriatic Disease -- IL-23 Inhibition for the Treatment of Psoriatic Disease: Pathway Discovery and Overview -- Combination Therapy with Biologic Agents -- Biologic Agents for the Treatment of Pediatric Psoriasis -- Special Site Psoriasis -- Comparing Biologic Agents in Treatment of Psoriasis -- Long Term Registry Data for Psoriasis Biologics -- Psoriasis Biologic Agents in Special Populations -- Psoriasis Biologics and the COVID-19 Pandemic: Lessons Learned -- Adherence to Biologic Therapy for Psoriasis.
Contained By:	Springer Nature eBook
Subject:	Psoriasis -
Online resource:	https://doi.org/10.1007/978-3-030-92938-1
ISBN:	9783030929381

Biologic therapy for psoriasis = cutting edge treatment principles /
Biologic therapy for psoriasiscutting edge treatment principles /[electronic resource] :edited by Nicholas Brownstone, Tina Bhutani, Wilson Liao. - Cham :Springer International Publishing :2022. - xvii, 146 p. :ill., digital ;24 cm. - Updates in clinical dermatology,2523-8892. - Updates in clinical dermatology..

Introduction to Biologic Therapy for Psoriasis -- Laboratory Monitoring: TB, Hepatitis and HIV -- TNF-Alpha Class of Biologic Agents in Psoriatic Disease -- IL-17 class of Biologic Agents in Psoriatic Disease -- IL-23 Inhibition for the Treatment of Psoriatic Disease: Pathway Discovery and Overview -- Combination Therapy with Biologic Agents -- Biologic Agents for the Treatment of Pediatric Psoriasis -- Special Site Psoriasis -- Comparing Biologic Agents in Treatment of Psoriasis -- Long Term Registry Data for Psoriasis Biologics -- Psoriasis Biologic Agents in Special Populations -- Psoriasis Biologics and the COVID-19 Pandemic: Lessons Learned -- Adherence to Biologic Therapy for Psoriasis.

Biologic therapy is a treatment that strives to modulate a patient's immune system to fight a given disease. In psoriasis, a skin disorder that is partly caused by a dysregulated immune system resulting in well-demarcated red areas of the skin with white scales, biologic therapy has the potential to vastly improve upon patient outcomes by minimizing the symptoms of this disease while maximizing the safety profile of the therapy. This book offers an up-to-date and comprehensive review on biologic therapy for the treatment of psoriasis. With over 10 FDA approved biologic agents for psoriasis (with more in the pipeline), confusion exists among providers regarding which agent is best for a particular patient. Chapters cover all FDA approved psoriasis biologic agents (including pipeline agents) for use in pediatric, adult, and geriatric patients. This book is unique in that it will not only cover cutting edge treatment principles based on the latest research, it will also be one of the most comprehensive reviews of psoriasis biologics in the COVID-19 era. Biologic Therapy for Psoriasis is a must-have resource for board certified dermatologists and rheumatologists, dermatology and rheumatology residents and fellows, dermatology physician assistants, nurse practitioners and medical students. The ultimate goal of this book is to improve patient care by making the busy practicing dermatology provider more adept with these particular therapies.

ISBN: 9783030929381

Standard No.: 10.1007/978-3-030-92938-1doiSubjects--Topical Terms:

923519
Psoriasis

LC Class. No.: RL321 / .B56 2022

Dewey Class. No.: 616.52606

Biologic therapy for psoriasis = cutting edge treatment principles /
LDR:03236nmm a2200337 a 4500 001 2299179
003 DE-He213
005 20220217110314.0
006 m d
007 cr nn 008maaau
008 230324s2022 sz s 0 eng d
020 $a 9783030929381 $q (electronic bk.)
020 $a 9783030929374 $q (paper)
024 7 $a 10.1007/978-3-030-92938-1 $2 doi
035 $a 978-3-030-92938-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RL321 $b .B56 2022
072 7 $a MJK $2 bicssc
072 7 $a MED017000 $2 bisacsh
072 7 $a MJK $2 thema
082 0 4 $a 616.52606 $2 23
090 $a RL321 $b .B615 2022
245 0 0 $a Biologic therapy for psoriasis $h [electronic resource] : $b cutting edge treatment principles / $c edited by Nicholas Brownstone, Tina Bhutani, Wilson Liao.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a xvii, 146 p. : $b ill., digital ; $c 24 cm.
490 1 $a Updates in clinical dermatology, $x 2523-8892
505 0 $a Introduction to Biologic Therapy for Psoriasis -- Laboratory Monitoring: TB, Hepatitis and HIV -- TNF-Alpha Class of Biologic Agents in Psoriatic Disease -- IL-17 class of Biologic Agents in Psoriatic Disease -- IL-23 Inhibition for the Treatment of Psoriatic Disease: Pathway Discovery and Overview -- Combination Therapy with Biologic Agents -- Biologic Agents for the Treatment of Pediatric Psoriasis -- Special Site Psoriasis -- Comparing Biologic Agents in Treatment of Psoriasis -- Long Term Registry Data for Psoriasis Biologics -- Psoriasis Biologic Agents in Special Populations -- Psoriasis Biologics and the COVID-19 Pandemic: Lessons Learned -- Adherence to Biologic Therapy for Psoriasis.
520 $a Biologic therapy is a treatment that strives to modulate a patient's immune system to fight a given disease. In psoriasis, a skin disorder that is partly caused by a dysregulated immune system resulting in well-demarcated red areas of the skin with white scales, biologic therapy has the potential to vastly improve upon patient outcomes by minimizing the symptoms of this disease while maximizing the safety profile of the therapy. This book offers an up-to-date and comprehensive review on biologic therapy for the treatment of psoriasis. With over 10 FDA approved biologic agents for psoriasis (with more in the pipeline), confusion exists among providers regarding which agent is best for a particular patient. Chapters cover all FDA approved psoriasis biologic agents (including pipeline agents) for use in pediatric, adult, and geriatric patients. This book is unique in that it will not only cover cutting edge treatment principles based on the latest research, it will also be one of the most comprehensive reviews of psoriasis biologics in the COVID-19 era. Biologic Therapy for Psoriasis is a must-have resource for board certified dermatologists and rheumatologists, dermatology and rheumatology residents and fellows, dermatology physician assistants, nurse practitioners and medical students. The ultimate goal of this book is to improve patient care by making the busy practicing dermatology provider more adept with these particular therapies.
650 0 $a Psoriasis $a Treatment. $3 923519
650 0 $a Dermatology. $3 829009
700 1 $a Brownstone, Nicholas. $3 3596465
700 1 $a Bhutani, Tina. $3 3596466
700 1 $a Liao, Wilson. $3 3596467
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Updates in clinical dermatology. $3 3309149
856 4 0 $u https://doi.org/10.1007/978-3-030-92938-1
950 $a Medicine (SpringerNature-11650)